HEPATITIS C VIRUS NUCLEIC ACID (HCV) - ANVISA Registration 80102513331

Access comprehensive regulatory information for HEPATITIS C VIRUS NUCLEIC ACID (HCV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80102513331 and manufactured by manufacturer not specified. The registration is held by VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MÉDICOS LTDA with validity until Dec 16, 2034.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT MOLECULAR INC, ROCHE MOLECULAR SYSTEMS, INC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80102513331
2 Related Devices
Registration Details
ANVISA Registration Number: 80102513331
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Kit de diagnóstico para quantificação de RNA do vírus da hepatite C (Sonda fluorescente de PCR)
Risk Class IV

Registration Details

80102513331

25351705204202386

04718143000194

Dates and Status

Dec 16, 2024

16/12/2034

09/18/2025 19:00:01

Kit de diagnóstico para quantificação de RNA do vírus da hepatite C (Sonda fluorescente de PCR)
Risk Class IV

Registration Details

80102513331

25351705204202386

04718143000194

Company Information

DAAN GENE CO., LTD
China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

Dec 16, 2024

16/12/2034

09/18/2025 19:00:01